Paper25239441
Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.
Glynne-Jones R and 9 others. Eur J Surg Oncol, 2014. Cited by 135 papers, by iCite.
Cite this record
ConductScience Library. Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up. Papers, record 25239441. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/25239441
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Anal cancer: ESMO-ESSO-ESTRO clinical practice guidelines for diagnosis, treatment and follow-up.
- PubMed
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anus Neoplasms | Major topic |
| Carcinoma, Squamous Cell | Major topic |
| Medical Oncology | Major topic |
| Combined Modality Therapy | |
| Female | |
| Follow-Up Studies | |
| Humans | |
| Lymphatic Metastasis | |
| Male | |
| Prognosis | |
| Societies, Medical |
Source PubMed
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 135 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42583054 | An overview of clinical trials in anal cancer 1999-2024. | ESMO Gastrointest Oncol | 2026 | https://conductscience.org/library/papers/42583054 | PubMed |
| 42232843 | Chemoradiotherapy for anal canal cancers: Does the choice of boost technique matter? | J Contemp Brachytherapy | 2026 | https://conductscience.org/library/papers/42232843 | PubMed |
| 41892185 | Liver Metastasectomy in Anal Squamous Cell Carcinoma: The Mayo Clinic Experience. | Curr Oncol | 2026 | https://conductscience.org/library/papers/41892185 | PubMed |
| 41832163 | An international multi-centre study to develop and validate federated learning-based prognostic models for anal cancer. | Nat Commun | 2026 | https://conductscience.org/library/papers/41832163 | PubMed |
| 41555561 | Diagnostic and Therapeutic Impact of FDG-PET/CT Following MRI Staging in Anal Cancer: A Systematic Review and Meta-Analysis. | J Med Imaging Radiat Oncol | 2026 | https://conductscience.org/library/papers/41555561 | PubMed |
| 40579585 | [Anal cancer-Interaction between outpatient and inpatient treatment]. | Chirurgie (Heidelb) | 2025 | https://conductscience.org/library/papers/40579585 | PubMed |
| 40282465 | Advances in the Management, Treatment, and Surveillance of Anal Squamous Cell Cancer. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/40282465 | PubMed |
| 40120019 | Radiomics to predict tumor response to combination chemoradiotherapy in squamous cell carcinoma of the anal canal: a preliminary investigation. | Eur Radiol Exp | 2025 | https://conductscience.org/library/papers/40120019 | PubMed |
| 39820172 | Comparative evaluation of TNM staging systems (eighth vs. ninth edition) for the non-surgical treatment of localized and locally advanced anal squamous cell carcinoma: Prognostic significance of T classification and lymph node status. | PLoS One | 2025 | https://conductscience.org/library/papers/39820172 | PubMed |
| 39542884 | Interstitial HDR brachytherapy for anal cancer-results and quality of life. | Strahlenther Onkol | 2025 | https://conductscience.org/library/papers/39542884 | PubMed |
| 39312693 | Anal carcinoma - exploring the epidemiology, risk factors, pathophysiology, diagnosis, and treatment. | World J Exp Med | 2024 | https://conductscience.org/library/papers/39312693 | PubMed |
| 39045410 | Prognostic and predictive role of YKL-40 in anal squamous cell carcinoma: a serological and tissue-based analysis in a multicentric cohort. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/39045410 | PubMed |
| 38456896 | Comparison between pelvic MRI, CT, and PET/CT in baseline staging and radiation planning of anal squamous cell carcinoma. | Abdom Radiol (NY) | 2024 | https://conductscience.org/library/papers/38456896 | PubMed |
| 37898965 | Uterine retroversion and gluteal transposition flap for postoperative perineal evisceration after extralevator abdominoperineal resection. | Updates Surg | 2024 | https://conductscience.org/library/papers/37898965 | PubMed |
| 37216622 | Clinicopathological Characteristics and Outcomes of Anal Squamous Cell Carcinoma Patients With and Without HIV Infection in Sub-Saharan Africa. | JCO Glob Oncol | 2023 | https://conductscience.org/library/papers/37216622 | PubMed |
| 37024606 | Follow-up imaging of anal cancer after treatment. | Abdom Radiol (NY) | 2023 | https://conductscience.org/library/papers/37024606 | PubMed |
| 36932225 | Imaging of Anal Squamous Cell Carcinoma: Survey Results and Expert Opinion from the Rectal and Anal Cancer Disease-Focused Panel of the Society of Abdominal Radiology. | Abdom Radiol (NY) | 2023 | https://conductscience.org/library/papers/36932225 | PubMed |
| 36910854 | Nonoperative management of gastrointestinal malignancies in era of neoadjuvant treatment. | Chin J Cancer Res | 2023 | https://conductscience.org/library/papers/36910854 | PubMed |
| 36402828 | Influence of radiation treatment technique (IMRT vs. 3D-RT) on acute toxicity and prognostic factors for survival for anal cancer. | Sci Rep | 2022 | https://conductscience.org/library/papers/36402828 | PubMed |
| 36388688 | Role of local therapy in the management of patients with metastatic anal squamous cell carcinoma: a National Cancer Database study. | J Gastrointest Oncol | 2022 | https://conductscience.org/library/papers/36388688 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/25239441
GET https://conductscience.org/api/papers/v1/25239441/cited_by?page=2